July 2006         

History:  The patient is a 66 year-old female with a significant history of metastatic breast cancer. She was first diagnosed eight years ago and received a lumpectomy, radiation therapy, and Tamoxifen.  Metastatic disease was found in the pelvis five years after breast cancer was treated, which was about 2003, and was treated at that time with Arimidex and Zometa.  It is noted that she has healing pelvic fractures.  She was previously taking medication for osteoporosis (drug name unknown.)  She is in clinic today for a submental (under the chin) mass that she noted about a month ago. It was thought to have been an infection and was given antibiotics. This mass never caused her any discomfort, never had any purulence or erythema.

A follow-up evaluation with a PET scan and bone scan revealed intense uptake of the radiopharmaceuticals in the mandible.  Both of the mentioned studies demonstrated some increased activity and possible metastasis to the anterior mandible. Other possible diagnosis are reactive lymph node, or associated with osteonecrosis of the mandible due to the prior bisphosphonate usage.

Physical Examination:
General: Well-nourished female in a wheelchair in no acute distress.
HEENT:  Oral cavity demonstrates edentulous on the mandible. Upper teeth are intact at present. Lower dentures were removed, and oral cavity was found to have no lesions or fullness.  The submentum was palpated, finding about a 1.5 to 2 cm firm nodule that is slightly mobile, though appears to be attached to the mandible. This did not appear to be salivary in nature.

MDP Bone Scan

FINDINGS: There are numerous foci of increased activity throughout the axial skeleton consistent with metastatic disease. These include the anterior mandible, the left side of T11, the left side of L1, the left side of L4, right side of L5. There is also increased activity in both posterior ilia, but the left is significantly worse than the right. There is also increased activity in both pubic bodies. Most of the left iliac crest is not visualized and appears to be photopenic defect that extends into the wing from there.

IMPRESSION:
1. WIDE SPREAD METASTATIC DISEASE WITH INCREASED ACTIVITY OF FOCI DESCRIBED ABOVE AND POSSIBLE LARGE COLD, LYTIC LESION IN THE LEFT ILIAC WING. SOME OF THESE CHANGES, ESPECIALLY THE CHANGES IN THE MID SPINE, MAY BE DEGENERATIVE IN NATURE.

ADDENDUM: Multiple foci of increased activity noted along the costochondral junctions on the right side of the chest most consistent with traumatic changes.


Excerpt from PET Scan Report: 
UPTAKE IN THE ANTERIOR MANDIBLE WHICH MAY REPRESENT INFECTION/OSTEONECROSIS FROM BISPHOPHONATE ADMINISTRATION AND LESS LIKELY A METASTATIC LESION.
 

Teaching Note:

An article in the July Pharmacy Today titled "Jaw Necrosis Linked to Bisphosphonate Use" reported "osteonecrosis of the jaw, a recently recognized adverse effect of biphosphonates, is a particularly difficult problem to manage.  According to a systematic review published recently in the Annals of Internal Medicine (www.annals.org), nearly all reported cases have involved patients with multiple myeloma or metastatic carcinoma who have received intravenous, nitrogen-containing bisphosphonates, chiefly pamidronate and zoledronic acid."

"Bisphosphonates can produce microdamage because they alter the bone deposition and repair processes.  Prolonged use of bisphosphonates may suppress bone turnover to the point that such microdamage persists and accumulates"  "Twice as many patients had problems with the mandible than the maxilla, and 60% of patients had a dental surgical procedure before developing osteonecrosis"  (Note the patient above had lower dentures).

Sook-Bin Woo, John W. Hellstein, and John R. Kalmar
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Ann Intern Med, May 2006; 144: 753 - 761.

 

Back to Newsletter

© 2006 Nuclear Education Online

Images courtesy of UAMS Dept of Nuclear Medicine.